IMARC Group’s latest research report, titled “Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” the global allergy immunotherapies market report reached a value of US$ 2.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.63 Billion by 2027, exhibiting at a CAGR of 10.2% during 2022-2027. Allergy immunotherapy, also called desensitization or hypo-sensitization, represents a preventive medical treatment for allergic reactions to allergens, such as various foods, bee venom, grass pollens, drugs, house dust mites, etc. It involves altering the immune system response by gradually increasing the doses of the allergen after an analysis of the triggering factors for allergy symptoms, which typically requires skin and blood tests. Allergy immunotherapy aids in reducing inflammation, offering long-term results, changing the course of the disease, enhancing immunological tolerance, improving the quality of the life of the patients, etc.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/allergy-immunotherapies-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by treatment type, allergy type and distribution channel.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for allergy immunotherapies market
- Strategies of major players and product offerings
The rising prevalence of allergies across the globe, on account of numerous environmental and lifestyle factors that, in turn, influence the functioning of the immune system, is primarily driving the allergy immonotherapies market. In addition to this, the elevating income levels of consumers and the growing healthcare expenditures are propelling the demand for sophisticated and long-term treatment options, which is further catalyzing the market growth. Moreover, the inflating investments in clinical research and development (R&D) activities by non-government and government bodies across countries are acting as significant growth-inducing factors. Furthermore, continuous developments in drug development technologies are enabling pharmaceutical firms to come up with more efficient immunotherapies for treating several allergies successfully, which is also augmenting the global market. Apart from this, the expanding allergy diagnostics sector is anticipated to fuel the allergy immonotherapies market over the forecasted period.
Key Players Included in Global Allergy Immunotherapies Market Research Report:
- ALK-Abello A/S
- Allergy Therapeutics
- Stallergenes Greer
- HAL Allergy Group
- DBV Technologies
- Merck Group
- Aimmune Therapeutics
- Circassia Pharmaceuticals
- Anergis SA
- Biomay AG etc.
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on treatment type, allergy type and distribution channel.
Breakup by Treatment Type:
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
Breakup by Allergy Type:
- Allergic Rhinitis
- Food Allergy
- Venom Allergy
Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
TOC for the Allergy Immunotherapies Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Allergy Immunotherapies Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800